SEC Form 4 · accession 0001225208-16-028358
LEGACY LIFEPOINT HEALTH, INC. · LPNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leif M. Murphy
Officer — EVP, CFO and CDO
Period of report
Feb 23, 2016
Accepted (ET)
Feb 25, 2016 · 7:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001301611
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Options (Right to buy)F1 | $64.22 | Feb 23, 2016 | A | 89,018 | A | — | Feb 23, 2026 | Common | 89,018 | 89,018 | D |
| Restricted Stock UnitsF2,F3 | $0.00 | Feb 23, 2016 | A | 24,035 | A | — | — | Common | 24,035 | 74,035 | D |
Explanation of responses
- F1The options vest in three equal installments beginning on the first anniversary of the date of grant.
- F2Upon vesting, the Reporting Person is entitled to receive up to two shares of Common Stock for each Restricted Stock Unit.
- F3The Performance Period with respect to these restricted stock units (RSUs) is January 1, 2016 through December 31, 2018. Each RSU represents the right to receive, upon vesting, up to two shares of the Issuer's common stock. Vesting of these performance-based RSUs is contingent criteria such as (i) the Issuer's three-year annualized total shareholder return or TSR as of December 31, 2018 relative to the S&P GICS Sub-industry: Health Care Facilities with over $500 million in revenues, or its equivalent; and (ii) the EBITDA of the Issuer and certain acquired facilities during the Performance Period.